Mediwound Ltd (MDWD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $185.63M
Last updated: Nov 17, 2026 at 11:04 AM ET
Mediwound Ltd (MDWD) Stock Forecast
Analysts expect Mediwound (MDWD) to earn -$1.93 per share in the fiscal year ending Dec 31, 2026, on revenue of $23.30M. Of 6 analysts, 6 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 3 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 6 ratings average 1.83, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 16.7% |
| Buy | 5 | 83.3% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 6
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates rise 37.9%.
- Fiscal year ending Dec 31, 2026
- -$1.93
- EPS consensus, revenue $23.30M
- Fiscal year ending Dec 31, 2027
- -$2.32
- EPS consensus, revenue $32.12M
- Next report
- Mar 3, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$1.93 | -$1.93 to -$1.93 | 1 | $23.30M | $21.09M to $25.32M | 5 |
| Dec 31, 2027 | -$2.32 | -$2.80 to -$2.00 | 5 | $32.12M | $29.59M to $34.00M | 5 |
Quarterly Estimates
The EPS consensus rises from -$0.65 for the quarter ending Dec 31, 2026 to -$0.64 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.65 | -$0.77 to -$0.55 | 8 | $12.00M | $4.31M to $16.70M | 8 |
| Mar 31, 2027 | -$0.64 | -$0.72 to -$0.55 | 4 | $7.32M | $6.66M to $8.50M | 5 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 4 upward and 7 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 3 | 1 |
| Fiscal year ending Dec 31, 2027 | 1 | 4 |
| Quarter ending Mar 31, 2027 | 0 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$2.23.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$1.93 | -$2.23 | -$2.23 | -$2.23 | -$2.23 | N/A |
| Fiscal year ending Dec 31, 2027 | -$2.32 | -$2.29 | -$2.29 | -$2.29 | -$2.29 | N/A |
| Quarter ending Mar 31, 2027 | -$0.64 | -$0.62 | -$0.62 | -$0.62 | -$0.62 | N/A |
Frequently Asked Questions About MDWD
What is the MDWD stock forecast?
Consensus analyst estimates put Mediwound's EPS at -$1.93 for the fiscal year ending Dec 31, 2026, on revenue of $23.30M. The consensus rating from 6 analysts is Buy.
How do analysts rate MDWD stock?
Of 6 analysts covering Mediwound, 1 rates it Strong Buy, 5 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from MDWD next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.93, with estimates from -$1.93 to -$1.93 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$2.32, with estimates from -$2.80 to -$2.00 from 5 analysts.
What revenue do analysts expect from Mediwound next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $23.30M, with estimates from $21.09M to $25.32M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $32.12M, with estimates from $29.59M to $34.00M.
How many analysts cover MDWD?
6 analysts rate Mediwound stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.
MDWD pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts